Enovis CORP (ENOV) stock
ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)
Close on Nov 18, 2026Market cap $1.56BP/E –Yield –
Enovis pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Enovis's pe ratio was 149.9× on Jan 31, 2023, against 56.8× a year earlier. Over the last 5 years it ranged from 21.5× to 149.9×, with a median of 35.3×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 149.9× | +22.4 |
| 2022 | Dec 30, 2022 | 127.4× | +63.9 |
| 2021 | Dec 31, 2021 | 63.6× | +15.0 |
| 2019 | Jul 31, 2019 | 48.6× | +24.8 |
| 2018 | Dec 31, 2018 | 23.8× | −4.2 |
| 2017 | Dec 29, 2017 | 27.9× | +1.1 |
| 2016 | Dec 30, 2016 | 26.8× | +15.5 |
| 2015 | Dec 31, 2015 | 11.3× | −8.2 |
| 2014 | Dec 31, 2014 | 19.5× | −28.1 |
| 2013 | Dec 31, 2013 | 47.5× | −291.4 |
| 2012 | Apr 30, 2012 | 338.9× | +296.5 |
| 2011 | Dec 30, 2011 | 42.4× | – |
See a number that looks wrong?